Pharyngotonsillitis, aphthous stomatitis, and adenitis precede familial Mediterranean fever by two decades
Journal of Internal Medicine · 03.11.2026
DOI: 10.1111/joim.70177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 03.11.2026. Verfasst von Eli Magen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adelson School of Medicine, Ariel University, Ariel, Israel. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Familial Mediterranean fever (FMF) and periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome share innate‐immune features, but population‐level data on oropharyngeal morbidity before FMF recognition are lacking.
Objectives
To examine the magnitude, timing, specificity, and treatment burden of a PFAPA‐like oropharyngeal phenotype in patients later diagnosed with FMF.
Methods
Population‐based matched case–control study in Leumit Health Services, Israel. FMF patients with colchicine dispensing ( n = 3324) were matched 1:4 by birth year and sex to 13,296 controls. Oropharyngeal diagnoses, tonsil/adenoid surgery, antibiotic dispensing, and ear, nose, and throat (ENT) visits were compared across windows up to 20 and 10 years before diagnosis (30‐day blackout), using streptococcal, hypertrophy, and non‐ENT negative controls with false discovery rate (FDR) adjustment.
Results
A PFAPA diagnostic code was recorded in 2.6% of FMF patients versus 0.1% of controls (odds ratio [OR] 25.4, 95% confidence interval 14.3–48.5). Up to 20 years before diagnosis, future FMF patients had more acute tonsillitis (35.6% vs. 27.2%; OR 1.48, 1.37–1.61), viral‐labeled tonsillitis (OR 2.65), oral aphthae (OR 1.72), and cervical lymphadenitis (OR 1.62; all q < 0.05); associations persisted after diagnosis. Streptococcal sore‐throat coding was not increased (lifelong OR 1.03, 0.94–1.14). Antibiotic dispensing and ENT visits were increased; tonsillectomy alone was more frequent (OR 2.51), although surgical comparisons did not survive FDR correction.
Conclusions
FMF is associated with a non‐streptococcal, PFAPA‐like oropharyngeal phenotype detectable years before diagnosis. Recurrent pharyngotonsillitis with aphthae or cervical adenitis, without demonstrated streptococcal disease, may be a clinical cue to consider FMF in at‐risk populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adelson School of Medicine, Ariel University, Ariel, Israel.
- Leumit Health Services, Tel Aviv, Israel.
- Rheumatology Unit, Assuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Urology Department, Assuta Ashdod University Hospital, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Epidemiology and Preventive Medicine, School of Public Health, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Eli Magen, Suhail Aamar, Israel Magen, Eugene Merzon, Ilan Green, Avivit Golan-Cohen, Shlomo Vinker, Ariel Israel
Zitieren
APA
Magen, E., Aamar, S., Magen, I., Merzon, E., Green, I., Golan-Cohen, A., Vinker, S., & Israel, A. (2026). Pharyngotonsillitis, aphthous stomatitis, and adenitis precede familial Mediterranean fever by two decades. Journal of Internal Medicine. https://doi.org/10.1111/joim.70177
Vancouver
Magen E, Aamar S, Magen I, Merzon E, Green I, Golan-Cohen A, et al. Pharyngotonsillitis, aphthous stomatitis, and adenitis precede familial Mediterranean fever by two decades. Journal of Internal Medicine. 2026. doi:10.1111/joim.70177
BibTeX
@article{Magen2026,
author = {Magen, Eli and Aamar, Suhail and Magen, Israel and Merzon, Eugene and Green, Ilan and Golan-Cohen, Avivit and Vinker, Shlomo and Israel, Ariel},
title = {Pharyngotonsillitis, aphthous stomatitis, and adenitis precede familial Mediterranean fever by two decades},
journal = {Journal of Internal Medicine},
year = {2026},
doi = {10.1111/joim.70177}
}
EUVIMED